Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
10000 participants
OBSERVATIONAL
2020-06-30
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
MAIN OBJECTIVE: To describe the incidence and type of arrhythmic events in the context of the SARS-CoV2 infection.
STUDY DESIGN: patient registry (observational). Patients will not undergo any additional investigations. Only data that is generated during routine clinical care will be collected.
STUDY POPULATION: Patients admitted to the hospital highly suspected of or with confirmed COVID-19.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Arrhythmic Manifestations and Management in Hospitalized COVID-19 Patients
NCT04465552
Study of Arrhythmia and ECG Abnormalities in Patients With COVID-19
NCT04937621
Non-invasive Differentiation of Supraventricular Tachyarrhythmia
NCT06061120
Clinical Cohort Study - TRUST
NCT05521451
Arrhythmias in Patients With COVID-19
NCT04395664
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The registry population will consist of patients presenting with a suspicion of SARS-CoV2 infection, who are hospitalised in a medical or surgical department of the participating hospitals. Patients will officially be enrolled in the COVIDAR Registry if the COVID-19 disease has formally been noted or confirmed in the patient's medical record.
The registry will include all patients and collect data at the following timepoints:
* Admission: evaluation before SARS-CoV2 infection treatment initiation
* On-treatment: evaluation 24-28h after treatment initiation
* At any adverse event: evaluation if any adverse event occurs
* At discharge: evaluation of clinical status at the end of the admission period.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COVID-19 patients
Patients admitted at one of the participating centres with highly suspected/confirmed infection with SARS-CoV-2.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER
Istituto Auxologico Italiano
OTHER
St George's University Hospitals NHS Foundation Trust
OTHER
University Hospital, Antwerp
OTHER
European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART)
UNKNOWN
European Society of Cardiology
NETWORK
Hospital Clinic of Barcelona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elena Arbelo, MD, PhD, MSc
Role: STUDY_CHAIR
Hospital Clinic of Barcelona
Arthur A Wilde, MD, PhD
Role: STUDY_DIRECTOR
Amsterdam UMC
Lia Crotti, MD, PhD
Role: STUDY_DIRECTOR
Istituto Auxologico Italiano, IRCCS
Elijah Behr, MD, PhD
Role: STUDY_DIRECTOR
St George's University Hospitals NHS Foundation Trust
Hein Heidbuchel, MD, PhD
Role: STUDY_DIRECTOR
University Hospital, Antwerp
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Antwerp University Hospital
Antwerp, , Belgium
Istituto Auxologico Italiano, IRCCS
Milan, , Italy
Amsterdam UMC
Amsterdam, AZ, Netherlands
Hospital Clinic of Barcelona
Barcelona, , Spain
St. Georges University Hospitals
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HCB/2020/0333
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.